Freespira is a medical device company that is developing non-pharmaceutical treatments for individuals with panic disorders, anxiety disorders, and post-traumatic stress disorder (PTSD). The company has developed a digital therapeutic that can reduce or eliminate symptoms of panic disorder, panic attacks, and post-traumatic stress disorder by training users to normalize respiratory irregularities.
Freespira's Product Videos
Compete with Freespira?
Ensure that your company and products are accurately represented on our platform.
Freespira's Products & Differentiators
Freespira is the only treatment demonstrated to significantly reduce or eliminate panic attacks and PTSD symptoms by training users to normalize respiratory irregularities.
Research containing Freespira
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Freespira in 1 CB Insights research brief, most recently on May 26, 2021.
Expert Collections containing Freespira
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Freespira is included in 5 Expert Collections, including Digital Health.
Companies developing and enabling evidence-based, software-driven therapeutic interventions to prevent, manage, or treat a medical disorder or disease. (*Scope follows the Digital Therapeutics Alliance definition)
Mental Health Tech
This collection includes companies applying technology to problems of emotional, psychological, and social well-being. Examples include companies working in areas such as substance abuse, eating disorders, stress reduction, depression, PTSD, and anxiety.
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
Freespira has filed 4 patents.
Sensors, Measurement, Systems of units, Carbon dioxide, Gas sensors
Sensors, Measurement, Systems of units, Carbon dioxide, Gas sensors
Latest Freespira News
Nov 30, 2022
News provided by Share this article Share this article Patients remained highly engaged during the four-week course of treatment, and about two-thirds of all patients experienced a significant drop in symptom severity KIRKLAND, Wash., Nov. 30, 2022 /PRNewswire/ -- Freespira, Inc., developer of the only FDA-cleared treatment for symptoms of panic disorder and post-traumatic stress disorder (PTSD), published a study showing the effectiveness of its at-home treatment to help patients with these mental health conditions. This data, which is in-line with prior clinical trial findings demonstrates the power of Freespira as an important tool in mental health care when used in conjunction with psychotherapy and medication, or as an adjunct option for patients who didn't respond to standard-of-care treatments. The real-world outcomes study , published in Frontiers in Digital Health, followed more than 1,500 patients with PTSD or panic disorder and reported that the Freespira treatment achieved a 75% adherence rate across both patient groups. The 1,395 patients with panic disorder had a response rate of 65%, and 174 patients with PTSD had a response rate of 72%. Freespira's chief clinical officer Robert Cuyler, Ph.D., led the study along with Michael Telch, Ph.D., professor of psychology and director of the Laboratory for the Study of Anxiety Disorders at the University of Texas at Austin. Telch is also a clinical practitioner specializing in evidence-based therapies for anxiety- and trauma-related disorders. "The Freespira treatment achieved impressive levels of effectiveness and adherence in this large sample of patients with panic attacks and PTSD, thus demonstrating its potential as a viable alternative to existing psychological or pharmacological treatments of panic and PTSD," said Telch. "The treatment uses a sophisticated respiratory feedback technology guided by personal coaching to help patients develop a greater sense of control and mastery of their physiological reactions, which we know play an important role in panic disorder and PTSD." Freespira's evidence-based, skill-building approach works by addressing the underlying physiological cause of panic attacks and PTSD symptoms: dysregulated breathing patterns associated with carbon dioxide (CO2) hypersensitivity. Working with a personal coach, patients are guided through twice-daily, 17-minute sessions to regulate their breathing over a four-week period. Freespira's sensor measures respiration rate and exhaled CO2 levels in real-time, and the connected app displays this objective physiological data to help patients visualize and develop beneficial breathing patterns. Freespira has treated over 4,000 patients to date. Since launching the PTSD indication, Freespira has been used in about 730 patients with PTSD, including over 150 veterans. "Freespira is addressing barriers to mental health care, including access and stigma, with our medication-free, at-home digital therapeutic. This real-world data shows that patients remain engaged throughout treatment, and they are seeing real relief from their symptoms," said Freespira Chief Executive Officer Joseph Perekupka. "We're committed to helping patients suffering from debilitating PTSD and panic disorder symptoms, and we will continue to show how Freespira is a viable treatment option along with psychotherapy and medication." Freespira is available to eligible veterans through the United States Department of Veteran Affairs. Freespira is also covered by a number of commercial health plans and managed medicaid plans, including Highmark, Chorus Community Health Plan and Security Health Plan, and is available to employees of Comcast. Freespira is actively working to engage with additional payers. About Freespira, Inc. Freespira, Inc. is the maker of Freespira, the only FDA-cleared digital therapeutic proven to significantly reduce or eliminate symptoms of panic attacks, panic disorder, and post-traumatic stress disorder (PTSD) in just 28 days by training users to normalize respiratory irregularities. Health plans, self-insured employers and the Veteran's Administration provide the company's drug-free solutions to improve quality of life, reduce medical expenditures and support the appropriate use of valuable healthcare resources. Find out how at www.freespira.com .
Freespira Frequently Asked Questions (FAQ)
When was Freespira founded?
Freespira was founded in 2008.
Where is Freespira's headquarters?
Freespira's headquarters is located at 12020 113th Ave NE, Kirkland.
What is Freespira's latest funding round?
Freespira's latest funding round is Series D.
How much did Freespira raise?
Freespira raised a total of $26.38M.
Who are the investors of Freespira?
Investors of Freespira include Aphelion Capital, Lightspeed Venture Partners and Medvest Capital.
Who are Freespira's competitors?
Competitors of Freespira include GrayMatters Health and 4 more.
What products does Freespira offer?
Freespira's products include Freespira.
Compare Freespira to Competitors
Big Health offers digital therapeutics servies including fully automated behavioral programs. The company offers Sleepio for users in need of help with sleep issues.
Twill provides digital therapeutics and care delivery models focused on mental and physical health. It partners with enterprises, pharma companies, and health plans to create new products that help support and manage specific mental and physical conditions. The company was formerly known as Happify Health and Happify. It was founded in 2012 and is based in New York, New York.
Modern Health is a mental health benefits platform for employers. The company covers the full spectrum of mental well-being needs through both evidence-based technology and professional support from a coach or therapist. Whether someone wants to proactively manage stress or treat depression, it guides people to the right care at the right time and helps companies save money in engagement and healthcare costs.
Spring Health provides mental health benefits for employers. Spring Health combines a digital platform with a vetted provider network, resulting in 2X higher recovery rates, shorter recovery times, and lower healthcare costs.
Quartet Health is a behavioral health technology company that has developed a suite of products to increase access to behavioral health resources. By aligning a quartet of key stakeholders – payers, behavioral health clinicians, medical providers, and patients – Quartet aims to deliver improved behavioral health care outcomes that also lower total cost of care.
Babyscripts Virtual Maternity Care is a clinically-validated, obstetrics-specific solution that allows OB/GYNs and other maternal health care providers to deliver a model of prenatal and postpartum care via a mobile app-based platform and remote patient monitoring. The company was founded in 2014 and is based in Washington, DC.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.